Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01039
Species: Homo sapiens
Position : chr7:116474936-116475436
Year: 2014
Title: Enhancer-targeted genome editing selectively blocks innate resistance to oncokinase inhibition
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
Disease Name: --
PMID:  24443471
MONDO:
Tissue: Inner cell mass
Tissue Ontology ID: UBERON:0000087
Cell Source: H1 hESCs
CVCL ID: CVCL_9771
Cell Type: embryonic stem cell
Cell Ontology ID: CL:0002322
Experiment Type: Enhancer activity assay, Chromatin interaction assay, Functional perturbation assay, TF binding assay
High Throughput Method: ChIP-seq, RNA-seq, 3C-seq, DNase-seq
Low Throughput Method: Luciferase Reporter Assay, CRISPR Knockout, RT-RT-qPCR, Western blot
About Target Gene
Target gene : MET
About TF
TF name : MITF
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
MITF IL6-mediated signaling events pid 48
MITF KitReceptor netpath 104
MITF RANKL netpath 84
MITF Regulation of nuclear beta catenin signaling and target gene transcription pid 80
MITF Regulation of retinoblastoma protein pid 67
MITF Signaling events mediated by Stem cell factor receptor (c-Kit) pid 53
MITF Signaling mediated by p38-alpha and p38-beta pid 35
MITF SUMOylation of transcription factors reactome 14
MITF Melanogenesis kegg 100
MITF Pathways in cancer kegg 321
MITF Melanoma kegg 69
MITF Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
MITF Hs_Kit_receptor_signaling_pathway_WP304_78799 wikipathways 46
MITF Hs_RANKL-RANK_(Receptor_activator_of_NFKB_(ligand))_Signaling_Pathway_WP2018_90016 wikipathways 26
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer